Latest period
108M
YoY change
-5.6%
5Y CAGR
-1.2%
Peak year (FY2016)
116M
Latest annual
109M
Shares Outstanding history chart for Regeneron Pharmaceuticals (REGN) from 2016 to 2025
Latest: 109M
Shares Outstanding growth chart for Regeneron Pharmaceuticals (REGN) from 2016 to 2025
Latest: -5.6%
Shares Outstanding history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
| FY2025 | 109M | -5.6% | -6.5M | ||
| FY2024 | 115M | +1.2% | +1.4M | ||
| FY2023 | 114M | +0.2% | +200K | ||
| FY2022 | 114M | +1.2% | +1.3M | ||
| FY2021 | 112M | -2.5% | -2.9M | ||
| FY2020 | 115M | +0.4% | +500K | ||
| FY2019 | 115M | -0.2% | -200K | ||
| FY2018 | 115M | -1.0% | -1.11M | ||
| FY2017 | 116M | -0.3% | -391K | ||
| FY2016 | 116M | +0.9% | +1.07M | ||
| FY2015 | 115M | +1.6% | +1.76M | ||
| FY2014 | 113M | +2.0% | +2.18M | ||
| FY2013 | 111M | -3.5% | -4.09M | ||
| FY2012 | 115M | +27.3% | +24.8M | ||
| FY2011 | 90.6M | +9.3% | +7.68M | ||
| FY2010 | 82.9M | +3.9% | +3.14M | ||
| FY2009 | 79.8M | +1.2% | +955K | ||
| FY2008 | 78.8M | +18.8% | +12.5M | ||
| FY2007 | 66.3M | +14.4% | +8.36M | ||
| FY2006 | 58M | +3.6% | +2.02M | ||
| FY2005 | 56M | -0.4% | -222K | ||
| FY2004 | 56.2M | +11.3% | +5.72M | ||
| FY2003 | 50.4M | +14.8% | +6.5M | ||
| FY2002 | 43.9M | +4.4% | +1.86M | ||
| FY2001 | 42.1M | +19.7% | +6.91M | ||
| FY2000 | 35.2M | +11.8% | +3.72M | ||
| FY1999 | 31.4M | +1.4% | +449K | ||
| FY1998 | 31M | +6.9% | +2M | ||
| FY1997 | 29M | +18.5% | +4.54M | ||
| FY1996 | 24.5M | +23.9% | +4.72M | ||
| FY1995 | 19.7M | +4.2% | +797K | ||
| FY1994 | 19M | +14.5% | +2.39M | ||
| FY1993 | 16.6M | +7.5% | +1.15M | ||
| FY1992 | 15.4M | -0.7% | -114K | ||
| FY1991 | 15.5M | +1.0% | +153K | ||
| FY1990 | 15.4M | — | — |
- FY2025109M-5.6%
- FY2024115M+1.2%
- FY2023114M+0.2%
- FY2022114M+1.2%
- FY2021112M-2.5%
- FY2020115M+0.4%
- FY2019115M-0.2%
- FY2018115M-1.0%
- FY2017116M-0.3%
- FY2016116M+0.9%
- FY2015115M+1.6%
- FY2014113M+2.0%
- FY2013111M-3.5%
- FY2012115M+27.3%
- FY201190.6M+9.3%
- FY201082.9M+3.9%
- FY200979.8M+1.2%
- FY200878.8M+18.8%
- FY200766.3M+14.4%
- FY200658M+3.6%
- FY200556M-0.4%
- FY200456.2M+11.3%
- FY200350.4M+14.8%
- FY200243.9M+4.4%
- FY200142.1M+19.7%
- FY200035.2M+11.8%
- FY199931.4M+1.4%
- FY199831M+6.9%
- FY199729M+18.5%
- FY199624.5M+23.9%
- FY199519.7M+4.2%
- FY199419M+14.5%
- FY199316.6M+7.5%
- FY199215.4M-0.7%
- FY199115.5M+1.0%
- FY199015.4M—
Shares Outstanding values are taken from Regeneron Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported diluted shares outstanding is 108M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Regeneron Pharmaceuticals (REGN) diluted shares outstanding is 109M – declined 5.6% year-over-year.
Regeneron Pharmaceuticals diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is -1.2%, with a net decline across the window.
Regeneron Pharmaceuticals diluted shares outstanding peaked at 116M in 2016; the latest annual figure is 109M in 2025 (6.6% below peak).
2016 marks the peak diluted shares outstanding at 116M, with the historical low of 15.4M recorded in 1990.
Regeneron Pharmaceuticals Shares Outstanding by Year
Regeneron Pharmaceuticals Shares Outstanding 2025: 109M
2025's diluted shares outstanding for Regeneron Pharmaceuticals came in at 109M, declined 5.6% below 2024.
Regeneron Pharmaceuticals Shares Outstanding 2024: 115M
Regeneron Pharmaceuticals posted diluted shares outstanding of 115M in 2024, edged up 1.2% from 2023.
Regeneron Pharmaceuticals Shares Outstanding 2023: 114M
In 2023, Regeneron Pharmaceuticals reported diluted shares outstanding of 114M, edged up 0.2% from 2022.
Regeneron Pharmaceuticals Shares Outstanding 2022: 114M
Regeneron Pharmaceuticals diluted shares outstanding in 2022 was 114M, edged up 1.2% from 2021.
Regeneron Pharmaceuticals Shares Outstanding 2021: 112M
Regeneron Pharmaceuticals diluted shares outstanding in 2021 was 112M.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers by Shares Outstanding
Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest diluted shares outstanding
Frequently asked questions
Regeneron Pharmaceuticals (REGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.